Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Interest Expenses (2021 - 2025)

Historic Interest Expenses for MDxHealth (MDXH) over the last 5 years, with Q2 2025 value amounting to -$6.3 million.

  • MDxHealth's Interest Expenses fell 4362.02% to -$6.3 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year decrease of 1309.64%. This contributed to the annual value of $15.3 million for FY2024, which is 1646.49% down from last year.
  • Latest data reveals that MDxHealth reported Interest Expenses of -$6.3 million as of Q2 2025, which was down 4362.02% from -$5.2 million recorded in Q1 2025.
  • In the past 5 years, MDxHealth's Interest Expenses registered a high of -$418000.0 during Q1 2022, and its lowest value of -$6.3 million during Q2 2025.
  • For the 5-year period, MDxHealth's Interest Expenses averaged around -$3.1 million, with its median value being -$3.1 million (2023).
  • In the last 5 years, MDxHealth's Interest Expenses tumbled by 61578.95% in 2023 and then surged by 5048.72% in 2024.
  • MDxHealth's Interest Expenses (Quarter) stood at -$835000.0 in 2021, then crashed by 302.75% to -$3.4 million in 2022, then plummeted by 31.22% to -$4.4 million in 2023, then skyrocketed by 50.49% to -$2.2 million in 2024, then tumbled by 187.96% to -$6.3 million in 2025.
  • Its last three reported values are -$6.3 million in Q2 2025, -$5.2 million for Q1 2025, and -$2.2 million during Q4 2024.